US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Advanced Biomed Inc.

5.10

+0.35007.37%

Post-market: 4.71-0.3900-7.65%18:19 EDT

Volume:16.55K

Turnover:80.49K

Market Cap:8.43M

PE:1.09

High:5.10

Open:4.73

Low:4.73

Close:4.75

52wk High:18.20

52wk Low:3.61

Shares:1.65M

Float Shares:735.20K

Volume Ratio:0.28

T/O Rate:2.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):4.67

EPS(LYR):-3.1755

ROE:71.33%

ROA:-21.50%

PB:0.91

PE(LYR):-1.61

Loading ...

Overview Company News Filings

Advanced Biomed Inc. and Chi-Mei Medical Center Launch Clinical Collaboration to Validate A+PerfusC Platform

Advanced Biomed Inc. Issues Amendment to June 2025 SEC Filing

Advanced Biomed Completes Private Placement Equity Financing

Advanced Biomed Inc. Sets Terms for HK Subsidiary Spin-Off Repayment

Advanced Biomed Inc. Files Information Statement Detailing Authorized Reverse Stock Split

Advanced Biomed Appeals Nasdaq Delisting, Plans Reverse Split

Nasdaq Threatens Delisting of Advanced Biomed Inc. Over Minimum Bid Price Rule

Advanced Biomed Inc. Files Draft Information Statement on Reverse Stock Split Authorization

Advanced Biomed Sells Hong Kong Subsidiary for $23,000

Advanced Biomed Inc. Announces Disposal of Its Hong Kong Subsidiary

THOMSON REUTERS

Advanced Biomed Q1 EPS $(0.02) Down From $(0.01) YoY

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADVB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADVB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADVB\",,,,,undefined,":{"symbol":"ADVB","market":"US","secType":"STK","nameCN":"Advanced Biomed Inc.","latestPrice":5.1,"timestamp":1781812800000,"preClose":4.75,"halted":0,"volume":16548,"hourTrading":{"tag":"盘后","latestPrice":4.71,"preClose":5.1,"latestTime":"18:19 EDT","volume":1627,"amount":7727.57,"timestamp":1781821174247,"change":-0.39,"changeRate":-0.076471,"amplitude":0.076471},"delay":0,"changeRate":0.07368421052631571,"floatShares":735200,"shares":1652100,"eps":4.665061,"marketStatus":"Market Closed","change":0.35,"latestTime":"06-18 16:00:00 EDT","open":4.73,"high":5.1,"low":4.73,"amount":80487.33068880001,"amplitude":0.077895,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.665061,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"listingDate":1740373200000,"exchange":"NASDAQ","adjPreClose":4.75,"preHourTrading":{"tag":"盘前","latestPrice":4.95,"preClose":4.95,"latestTime":"07:31 EDT","volume":12,"amount":57.819992400000004,"timestamp":1781782262850,"change":0,"changeRate":0,"amplitude":0.10101},"postHourTrading":{"tag":"盘后","latestPrice":4.71,"preClose":5.1,"latestTime":"18:19 EDT","volume":1627,"amount":7727.57,"timestamp":1781821174247,"change":-0.39,"changeRate":-0.076471,"amplitude":0.076471},"volumeRatio":0.28124968170755293},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADVB\",,,,,undefined,":{"symbol":"ADVB","floatShares":735200,"roa":"-21.50%","roe":"71.33%","lyrEps":-3.1755,"volumeRatio":0.28124968170755293,"shares":1652100,"dividePrice":0,"high":5.1,"amplitude":0.077895,"preClose":4.75,"low":4.73,"week52Low":3.61,"pbRate":"0.91","week52High":18.2,"institutionHeld":0,"latestPrice":5.1,"eps":4.665061,"divideRate":0,"volume":16548,"delay":0,"ttmEps":4.665061,"open":4.73,"prevYearClose":5.836,"prevWeekClose":4.5,"prevMonthClose":5.01,"prevQuarterClose":4.56,"fiveDayClose":4.01,"twentyDayClose":4.44,"sixtyDayClose":4.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADVB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"ADVB","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2026-02-20","symbol":"ADVB","defaultRemindTime":1771597800000,"type":"split","dateTimestamp":1771563600000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2026-02-13","symbol":"ADVB","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770958800000,"reportTimeType":"post","actualEps":0.32},{"market":"US","date":"2025-11-19","symbol":"ADVB","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763528400000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2025-10-08","symbol":"ADVB","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1759896000000,"reportTimeType":"post","actualEps":-0.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADVB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADVB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADVB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADVB","date":"2026-06-18","current":1.093233,"percent":0.891641,"low":-47.528225,"twenty":-6.127022,"median":-2.743373,"eighty":1.302352,"high":2.240242,"avg":-5.271714,"sd":9.54578,"marketCap":7847631},"quantilePoints":[{"date":"2025-03-07","current":-34.695604,"twenty":-44.961701,"median":-41.111914,"eighty":-37.262128,"marketCap":78986000},{"date":"2025-03-14","current":-33.554927,"twenty":-36.006243,"median":-34.695604,"eighty":-33.783062,"marketCap":76389200},{"date":"2025-03-21","current":-34.980773,"twenty":-36.083428,"median":-34.885717,"eighty":-34.695604,"marketCap":79635200},{"date":"2025-03-28","current":-37.737411,"twenty":-37.053955,"median":-35.931338,"eighty":-34.695604,"marketCap":85910800},{"date":"2025-04-04","current":-33.174701,"twenty":-37.224296,"median":-36.026394,"eighty":-34.695604,"marketCap":75523600},{"date":"2025-04-11","current":-17.110161,"twenty":-37.053955,"median":-34.980773,"eighty":-33.220518,"marketCap":38952000},{"date":"2025-04-17","current":-13.671411,"twenty":-36.977909,"median":-34.790661,"eighty":-18.773649,"marketCap":41548800},{"date":"2025-04-25","current":-13.24418,"twenty":-36.976959,"median":-34.695604,"eighty":-17.110161,"marketCap":40250400},{"date":"2025-05-02","current":-13.600206,"twenty":-36.501677,"median":-33.403787,"eighty":-13.675684,"marketCap":41332400},{"date":"2025-05-09","current":-7.618964,"twenty":-36.390461,"median":-29.752668,"eighty":-13.600206,"marketCap":23154800},{"date":"2025-05-16","current":-8.259811,"twenty":-36.121451,"median":-18.060725,"eighty":-12.888153,"marketCap":25102400},{"date":"2025-05-23","current":-7.648814,"twenty":-35.931338,"median":-17.157689,"eighty":-11.749581,"marketCap":25751600},{"date":"2025-05-30","current":-7.134608,"twenty":-35.622595,"median":-15.497072,"eighty":-8.13731,"marketCap":24020400},{"date":"2025-06-06","current":-5.980859,"twenty":-35.0937,"median":-14.241054,"eighty":-7.642844,"marketCap":20136020},{"date":"2025-06-13","current":-6.15826,"twenty":-34.904728,"median":-13.673548,"eighty":-7.314536,"marketCap":20733284},{"date":"2025-06-20","current":-4.982013,"twenty":-34.828683,"median":-13.600206,"eighty":-6.701905,"marketCap":16773164},{"date":"2025-06-27","current":-4.086652,"twenty":-34.733627,"median":-13.24418,"eighty":-6.167515,"marketCap":13758712},{"date":"2025-07-03","current":-4.377179,"twenty":-34.695604,"median":-12.888153,"eighty":-6.106196,"marketCap":14736840},{"date":"2025-07-11","current":-5.046932,"twenty":-34.695604,"median":-11.820431,"eighty":-5.97276,"marketCap":16991728},{"date":"2025-07-18","current":-4.735195,"twenty":-34.239333,"median":-8.259811,"eighty":-5.140899,"marketCap":15942188},{"date":"2025-07-25","current":-3.471533,"twenty":-33.494471,"median":-7.876672,"eighty":-4.892927,"marketCap":11687764},{"date":"2025-08-01","current":-2.972111,"twenty":-33.312153,"median":-7.648814,"eighty":-4.638141,"marketCap":10006336},{"date":"2025-08-08","current":-2.443121,"twenty":-32.680407,"median":-7.520585,"eighty":-4.430399,"marketCap":8225364},{"date":"2025-08-15","current":-2.815921,"twenty":-30.189928,"median":-7.262937,"eighty":-4.33701,"marketCap":9480484},{"date":"2025-08-22","current":-2.688012,"twenty":-24.049282,"median":-6.688214,"eighty":-4.106192,"marketCap":9049848},{"date":"2025-08-29","current":-2.7645,"twenty":-18.488479,"median":-6.376432,"eighty":-3.471148,"marketCap":9307364},{"date":"2025-09-05","current":-2.763215,"twenty":-17.927646,"median":-6.164045,"eighty":-3.222786,"marketCap":9303036},{"date":"2025-09-12","current":-3.134086,"twenty":-17.357307,"median":-6.106196,"eighty":-2.994607,"marketCap":10551664},{"date":"2025-09-19","current":-3.621296,"twenty":-17.186206,"median":-5.984072,"eighty":-3.094492,"marketCap":12191976},{"date":"2025-09-26","current":-3.02096,"twenty":-16.939059,"median":-5.947757,"eighty":-2.97751,"marketCap":10170800},{"date":"2025-10-03","current":-2.93226,"twenty":-15.95162,"median":-5.14206,"eighty":-2.925318,"marketCap":9872168},{"date":"2025-10-10","current":-3.173985,"twenty":-14.640088,"median":-5.047575,"eighty":-2.931231,"marketCap":10343920},{"date":"2025-10-17","current":-2.682615,"twenty":-14.242193,"median":-4.833536,"eighty":-2.891766,"marketCap":8742560},{"date":"2025-10-24","current":-2.92166,"twenty":-14.169849,"median":-4.694383,"eighty":-2.891766,"marketCap":9521600},{"date":"2025-10-31","current":-3.765622,"twenty":-13.843158,"median":-4.563578,"eighty":-2.905972,"marketCap":12272044},{"date":"2025-11-07","current":-2.91834,"twenty":-13.674829,"median":-4.434385,"eighty":-2.919004,"marketCap":9510780},{"date":"2025-11-14","current":-2.975445,"twenty":-13.65717,"median":-4.377179,"eighty":-2.891766,"marketCap":9696884},{"date":"2025-11-21","current":-2.506652,"twenty":-13.600206,"median":-4.291213,"eighty":-2.871008,"marketCap":8169100},{"date":"2025-11-28","current":-2.689404,"twenty":-13.600206,"median":-4.191422,"eighty":-2.846773,"marketCap":9090964},{"date":"2025-12-05","current":-2.433971,"twenty":-13.529001,"median":-4.086652,"eighty":-2.808208,"marketCap":8227528},{"date":"2025-12-12","current":-2.340505,"twenty":-13.24418,"median":-3.693459,"eighty":-2.7645,"marketCap":7911584},{"date":"2025-12-19","current":-2.204146,"twenty":-12.888153,"median":-3.612297,"eighty":-2.746361,"marketCap":7450652},{"date":"2025-12-26","current":-2.400682,"twenty":-12.888153,"median":-3.470891,"eighty":-2.714113,"marketCap":8115000},{"date":"2026-01-02","current":-1.86805,"twenty":-12.71726,"median":-3.342982,"eighty":-2.704002,"marketCap":6314552},{"date":"2026-01-09","current":-2.269444,"twenty":-12.176101,"median":-3.263775,"eighty":-2.689148,"marketCap":7671380},{"date":"2026-01-16","current":-2.027456,"twenty":-11.806261,"median":-3.212502,"eighty":-2.659467,"marketCap":6853388},{"date":"2026-01-23","current":-2.179179,"twenty":-10.439119,"median":-3.19125,"eighty":-2.588642,"marketCap":7366256},{"date":"2026-01-30","current":-1.772894,"twenty":-8.387981,"median":-3.154035,"eighty":-2.522163,"marketCap":5992895},{"date":"2026-02-06","current":-1.81285,"twenty":-8.221095,"median":-3.118208,"eighty":-2.488771,"marketCap":6127960},{"date":"2026-02-13","current":-1.917452,"twenty":-8.1116,"median":-3.072381,"eighty":-2.446887,"marketCap":6481543},{"date":"2026-02-20","current":1.410729,"twenty":-7.97135,"median":-3.041183,"eighty":-2.432947,"marketCap":6186801},{"date":"2026-02-27","current":1.24769,"twenty":-7.717718,"median":-3.02096,"eighty":-2.380708,"marketCap":5471789},{"date":"2026-03-06","current":1.266359,"twenty":-7.700235,"median":-2.997178,"eighty":-2.333847,"marketCap":5553661},{"date":"2026-03-13","current":1.667735,"twenty":-7.642844,"median":-2.975445,"eighty":-2.301581,"marketCap":7313912},{"date":"2026-03-20","current":1.305252,"twenty":-7.612079,"median":-2.950705,"eighty":-2.242044,"marketCap":5724228},{"date":"2026-03-27","current":1.303696,"twenty":-7.558957,"median":-2.937597,"eighty":-2.157413,"marketCap":5717405},{"date":"2026-04-02","current":1.387705,"twenty":-7.45663,"median":-2.930974,"eighty":-2.105558,"marketCap":6085830},{"date":"2026-04-10","current":2.081558,"twenty":-7.327436,"median":-2.922782,"eighty":-2.027456,"marketCap":9128745},{"date":"2026-04-17","current":1.48416,"twenty":-7.262937,"median":-2.90205,"eighty":-1.965998,"marketCap":6508836},{"date":"2026-04-24","current":2.013106,"twenty":-7.134608,"median":-2.884696,"eighty":-1.917452,"marketCap":8828547},{"date":"2026-05-01","current":1.664624,"twenty":-6.756668,"median":-2.868871,"eighty":-1.81285,"marketCap":7300267},{"date":"2026-05-08","current":2.240242,"twenty":-6.61976,"median":-2.85609,"eighty":-1.758996,"marketCap":9824659},{"date":"2026-05-15","current":1.651108,"twenty":-6.427575,"median":-2.815921,"eighty":1.244578,"marketCap":7240994},{"date":"2026-05-22","current":1.278416,"twenty":-6.376432,"median":-2.806501,"eighty":1.263994,"marketCap":6750633},{"date":"2026-05-29","current":1.223346,"twenty":-6.21115,"median":-2.784897,"eighty":1.263396,"marketCap":6459840},{"date":"2026-06-05","current":1.332853,"twenty":-6.165202,"median":-2.763857,"eighty":1.29125,"marketCap":7038086},{"date":"2026-06-12","current":1.254634,"twenty":-6.159417,"median":-2.746753,"eighty":1.29125,"marketCap":6625053},{"date":"2026-06-18","current":1.486162,"twenty":-6.127022,"median":-2.743373,"eighty":1.302352,"marketCap":7847631}],"updateTime":1781990147609},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADVB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611152420","title":"Advanced Biomed Inc. and Chi-Mei Medical Center Launch Clinical Collaboration to Validate A+PerfusC Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2611152420","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611152420?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:00","pubTimestamp":1770987636,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. has announced a clinical research collaboration with Chi-Mei Medical Center to conduct a 120-case feasibility study evaluating the predictive accuracy of the A+PerfusC integrated perfusion 3D cell culture platform. The study will assess how well drug sensitivity results from the A+PerfusC platform, derived from circulating tumor cells obtained via liquid biopsy, correlate with actual patient outcomes. Both parties will share rights to project-related intellectual property and research outcomes, with interim data expected in mid-2026 and full results targeted by year-end. The collaboration aims to advance precision oncology by providing functional, patient-specific drug response data to guide therapy selection.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL6LG1FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4112","IE00BKPKM429.USD","BK4198","SG9999014013.SGD","IE00B64PRP62.GBP","BK4585","SG9999014039.USD","LU2210149790.SGD","BK4588","NDAQ","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610067503","title":"Advanced Biomed Inc. Issues Amendment to June 2025 SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2610067503","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610067503?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:01","pubTimestamp":1770757281,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. has filed an amendment to its previously issued Form 8-K report with the U.S. Securities and Exchange Commission. The amendment, dated February 10, 2026, serves to supplement and clarify disclosures made in the original filing from June 6, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDLbRCBYm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608815881","title":"Advanced Biomed Completes Private Placement Equity Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2608815881","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608815881?lang=en_us&edition=fundamental","pubTime":"2026-02-03 06:10","pubTimestamp":1770070209,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. ( ($ADVB) ) has shared an update. On January 28, 2026, Advanced Biomed Inc., a Nevada corporation, entered into a securities p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-completes-private-placement-equity-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-completes-private-placement-equity-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADVB","EQR","BK4585","BK4198","BK4588","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606175355","title":"Advanced Biomed Inc. Sets Terms for HK Subsidiary Spin-Off Repayment","url":"https://stock-news.laohu8.com/highlight/detail?id=2606175355","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606175355?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:31","pubTimestamp":1769549479,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. has entered into a supplemental agreement related to the previously disclosed sale of its wholly owned subsidiary, Advanced Biomed  Limited, to Wei Ha Hui. As part of the updated terms, Advanced Biomed  Limited has acknowledged owing the parent company $6,925,549, reflecting outstanding accounts receivable as of the agreement dates. Under the new arrangement, Advanced Biomed  Limited has agreed to repay the debt in full within one year of the supplemental agreement. The company’s board of directors has unanimously approved the supplemental agreement and the related transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDG","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL9CqBNk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605881142","title":"Advanced Biomed Inc. Files Information Statement Detailing Authorized Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2605881142","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605881142?lang=en_us&edition=fundamental","pubTime":"2026-01-24 05:01","pubTimestamp":1769202081,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. shareholders have authorized a reverse stock split of the company’s issued and outstanding common shares, at a ratio ranging from one-for-two (1:2) to one-for-one hundred . The corporate action was approved by written consent of the majority stockholders on January 12, 2026. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nNDL6sFB54:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605439518","title":"Advanced Biomed Appeals Nasdaq Delisting, Plans Reverse Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2605439518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605439518?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:30","pubTimestamp":1769034620,"startTime":"0","endTime":"0","summary":"The latest update is out from Advanced Biomed Inc. ( ($ADVB) ). On July 18, 2025, Advanced Biomed Inc. was notified by Nasdaq that its common stock...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-appeals-nasdaq-delisting-plans-reverse-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-appeals-nasdaq-delisting-plans-reverse-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","ADVB","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605435072","title":"Nasdaq Threatens Delisting of Advanced Biomed Inc. Over Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2605435072","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605435072?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:01","pubTimestamp":1769032890,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. is facing potential delisting from the Nasdaq Capital Market after failing to meet the minimum $1.00 per share bid price requirement, as mandated by Nasdaq Listing Rule 5550. The company did not regain compliance by the January 14, 2026 deadline and subsequently received notice that its securities would be suspended and delisted unless an appeal was filed. Advanced Biomed appealed the decision, which temporarily stays the delisting process while a hearings panel reviews the case. The company plans to present a compliance strategy, including a reverse stock split, but there is no assurance the panel will approve continued listing or that compliance will be achieved within any granted timeframe.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDLbZPXsZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603842526","title":"Advanced Biomed Inc. Files Draft Information Statement on Reverse Stock Split Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2603842526","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603842526?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:00","pubTimestamp":1768251638,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. shareholders have authorized a reverse stock split of the company’s issued and outstanding common shares, with the split ratio to be determined by the Board of Directors within a range of one-for-two (1:2) to one-for-one hundred . The corporate actions were approved by the majority stockholders on January 12, 2026. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL54cgTz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595713062","title":"Advanced Biomed Sells Hong Kong Subsidiary for $23,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2595713062","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595713062?lang=en_us&edition=fundamental","pubTime":"2025-12-30 23:17","pubTimestamp":1767107830,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. has entered into an agreement to sell 100% of the issued and outstanding shares of its Hong Kong subsidiary, Advanced Biomed  Limited, to an unrelated third party, Wei Ha Hui, for a total purchase price of US$23,000. As part of the transaction, all intellectual property held by the Hong Kong subsidiary, including that of Shanghai Sglcell Biotech Co., Ltd., has been transferred to the buyer. The decision was made to address evolving regulatory requirements in China and to streamline the company’s clinical trials and product development through its Taiwan subsidiary. The transaction closed on December 23, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDLbgVm9q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","SG9999014013.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","LU0314104364.USD","SG9999014021.USD","LU2210149790.SGD","SG9999014039.USD","BK4588","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4198","IE00B64PRP62.GBP","BK4585","LU2095319765.USD","LU2210150020.SGD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595054713","title":"Advanced Biomed Inc. Announces Disposal of Its Hong Kong Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2595054713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595054713?lang=en_us&edition=fundamental","pubTime":"2025-12-30 23:17","pubTimestamp":1767107826,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584397213","title":"Advanced Biomed Q1 EPS $(0.02) Down From $(0.01) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2584397213","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584397213?lang=en_us&edition=fundamental","pubTime":"2025-11-20 08:00","pubTimestamp":1763596846,"startTime":"0","endTime":"0","summary":"Advanced Biomed (NASDAQ:ADVB) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48965982/advanced-biomed-q1-eps-0-02-down-from-0-01-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":31,"code":"91000000","status":"200"}]}}